Innovating Works
GLIOMATCH: The malignant Glioma immuno-oncology matchmaker: towards data-driven precision medicine using spatia... ASPECT ANALYTICS participó en un HORIZON EUROPE HORIZON-MISS-2023-CANCER-01 "Adult and paediatric malignant glioma (GBM and pHGG) remain among the most difficult-to-treat cancers with 5-year survival rates of <5% des...
2023-12-07 - 2028-12-31 | financed
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.